Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Secondary Messengers in Hormone Action01:26

Secondary Messengers in Hormone Action

Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.

Scientific reports·2018
Same author

Guideline. Diagnosis and treatment of venous malformations. consensus document of the international union of phlebology (iup): updated-2013.

International angiology : a journal of the International Union of Angiology·2014
Same author

Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013.

International angiology : a journal of the International Union of Angiology·2014
Same author

The PCAST report: impact and implications for the pharmaceutical industry.

Clinical pharmacology and therapeutics·2013
Same author

Gynecological chair syncope in elderly women: practical implications for general practitioners and gynecologists.

The International journal of risk & safety in medicine·2013
Same author

Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management.

International angiology : a journal of the International Union of Angiology·2013

Related Experiment Video

Updated: Jul 5, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Parathyroid hormone-receptor interactions.

M P Caulfield1, M Rosenblatt

  • 1Department of Biological Research and Molecular Biology, Merck Sharp and Dohme Research Laboratories, West Point, PA0 19486, USA.

Trends in Endocrinology and Metabolism: TEM
|January 1, 1990
PubMed
Summary

New parathyroid hormone (PTH) antagonists were designed by identifying "tolerant" sites in PTH antagonist peptides. These modifications enhance potency by improving ligand-receptor interaction without causing signal transduction, applicable to PTH-related protein (PTHrP) antagonists too.

More Related Videos

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: Jul 5, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Peptide Chemistry
  • Molecular Pharmacology

Background:

  • Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) play crucial roles in calcium homeostasis and bone metabolism.
  • PTH antagonists are being investigated for therapeutic applications, but their potency and efficacy require optimization.
  • Understanding the structure-activity relationships of PTH antagonists is key to designing improved therapeutics.

Purpose of the Study:

  • To design novel, more potent antagonists of parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP).
  • To identify specific amino acid sites within antagonist peptides that tolerate substitutions without compromising antagonist activity.
  • To investigate methods for enhancing ligand-receptor interactions and eliminating partial agonism in PTH analogs.

Main Methods:

  • Identification of amino acid sites in PTH antagonist peptides that are tolerant to a wide range of substitutions.
  • Rational design of new PTH antagonists incorporating specific amino acid substitutions at identified tolerant sites.
  • Modification of PTHrP antagonists using similar strategies to enhance potency.
  • Residue exchange between PTH and PTHrP analogs to eliminate partial agonism.

Main Results:

  • Successfully designed novel PTH antagonists with increased potency due to strategic amino acid substitutions.
  • Substitutions at specific sites enhanced ligand-receptor interaction without inducing signal transduction.
  • Similar modifications applied to PTHrP antagonists also resulted in increased potency.
  • Partial agonism observed in an analog was successfully removed through residue exchange between PTH and PTHrP.

Conclusions:

  • Amino acid substitutions at specific 'tolerant' sites represent a viable strategy for designing potent PTH and PTHrP antagonists.
  • Enhancing ligand-receptor interaction while preventing signal transduction is crucial for developing effective antagonists.
  • The ability to fine-tune agonistic/antagonistic properties through residue exchange offers further therapeutic potential.